Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• MertensLSNeuzilletYHorenblasSvan RhijnBWLandmarks in non-muscle-invasive bladder cancerNat Rev Urol201411847648024980189
   PubMed Web of Science ®Google Scholar
• MoonDGLeeSEOhMMNVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cellsInt J Oncol20144531027103524969552
   PubMed Web of Science ®Google Scholar
• StenzlACowanNCDe SantisMTreatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelinesEur Urol20115961009101821454009
   PubMed Web of Science ®Google Scholar
• GadeaGBlangyADock-family exchange factors in cell migration and diseaseEur J Cell Biol20149310–1246647725022758
   PubMed Web of Science ®Google Scholar
• BoureuxAVignalEFaureSFortPEvolution of the Rho family of ras-like GTPases in eukaryotesMol Biol Evol200724120321617035353
   PubMed Web of Science ®Google Scholar
• EricksonMRGallettaBJAbmayrSMDrosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organizationJ Cell Biol199713835896039245788
   PubMed Web of Science ®Google Scholar
• WuYCHorvitzHRC. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180Nature199839266755015049548255
   PubMed Web of Science ®Google Scholar
• JarzynkaMJHuBHuiKMELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasionCancer Res200767157203721117671188
   PubMed Web of Science ®Google Scholar
• ZhaoFSiuMKJiangLOverexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survivalHistopathology20115961163117222175896
   PubMed Web of Science ®Google Scholar
• WangJDaiJMCheYLElmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancerInt J Gynecol Cancer201424584485024819662
   PubMed Web of Science ®Google Scholar
• FengHHuBVuoriKEGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180Oncogene201433192504251223728337
   PubMed Web of Science ®Google Scholar
• FengHHuBLiuKWActivation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRalpha-stimulated glioma tumorigenesis in mice and humansJ Clin Invest2011121124670468422080864
   PubMed Web of Science ®Google Scholar
• FengHHuBJarzynkaMJPhosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesisProc Natl Acad Sci U S A201210983018302322323579
   PubMed Web of Science ®Google Scholar
• ChehrehasaFMeedeniyaACDwyerPAbrahamsenGMackay-SimAEdU, a new thymidine analogue for labelling proliferating cells in the nervous systemJ Neurosci Methods2009177112213018996411
   PubMed Web of Science ®Google Scholar
• JingYCuiDGuoWActivated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transitionCancer Lett20143481–213514524662746
   PubMed Web of Science ®Google Scholar
• ChafferCLBrennanJPSlavinJLBlickTThompsonEWWilliamsEDMesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2Cancer Res20066623112711127817145872
   PubMed Web of Science ®Google Scholar
• CostelloJCTheodorescuDDecade in review-bladder cancer: international progress: from cytology to genomicsNat Rev Urol2014111160961025179501
   PubMed Web of Science ®Google Scholar
• LaurinMDumouchelAFukuiYCoteJFThe Rac-specific exchange factors Dock1 and Dock5 are dispensable for the establishment of the glomerular filtration barrier in vivoSmall GTPases20134422123024365888
   PubMedGoogle Scholar
• LaurinMFradetNBlangyAHallAVuoriKCôtéJFThe atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivoProc Natl Acad Sci U S A200810540154461545118820033
   PubMed Web of Science ®Google Scholar
• LaurinMHuberJPelletierARac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasisProc Natl Acad Sci U S A2013110187434743923592719
   PubMed Web of Science ®Google Scholar
• PanYLiXDuanJEnoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activationMol Pharmacol201587337839025488183
   PubMed Web of Science ®Google Scholar
• HanzeJHenriciMHegeleAHofmannROlbertPJEpithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cellsBMC Cancer20131358924325461
   PubMed Web of Science ®Google Scholar
• TranMNChoiWWszolekMFThe p63 protein isoform DeltaN-p63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205J Biol Chem201328853275328823239884
   PubMed Web of Science ®Google Scholar
• LiWKidiyoorAHuYEvaluation of transforming growth factor-beta1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cellsTumour Biol20153621155116225722217
   PubMedGoogle Scholar
• IslamSSMokhtariRBNomanASSonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancerMol Carcinog Epub201531
   PubMed Web of Science ®Google Scholar
• ZhangJWeiJLuJOverexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3beta/Snail signalingCarcinogenesis201334102401240823722651
   PubMed Web of Science ®Google Scholar
• ThomsonSPettiFSujka-KwokIA systems view of epithelial-mesenchymal transition signaling statesClin Exp Metastasis201128213715521194007
   PubMed Web of Science ®Google Scholar
• MassariFSantoniMCiccareseCEmerging concepts on drug resistance in bladder cancer: Implications for future strategiesCrit Rev Oncol Hematol2015961819026022449
   PubMed Web of Science ®Google Scholar
• TadaYWadaMMigitaTIncreased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicinInt J Cancer200298463063511920626
   PubMed Web of Science ®Google Scholar
• YuSMengQHuHZhangMCorrelation of ANXA1 expression with drug resistance and relapse in bladder cancerInt J Clin Exp Pathol2014795538554825337195
   PubMed Web of Science ®Google Scholar